The Department of Defense's Defense Health Agency awarded a $199,973 Project Grant to the Metis Foundation, a non-profit organization, to support research on the local delivery of bioengineered mesenchymal stem cell-derived extracellular vesicles for targeted immunomodulation in vascularized composite allotransplantation. This grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform...
The Defense Health Agency awarded a $398,107 Cooperative Agreement to the Metis Foundation, a non-profit organization, under the Military Medical Research and Development program (CFDA 12.420). The funding supports a 3-year project to develop a multi-modal approach to reduce vascularized composite allotransplantation (VCA) immunogenicity and improve functional outcomes. The Metis Foundation has an extensive history providing medical research, products, and services through prime and sub...
This $1,845,076 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports Metis Foundation, a non-profit organization in San Antonio, Texas, to conduct novel research on therapeutic approaches targeting the innate immune system for treating multiple organ failure in severe polytrauma during prolonged casualty care. The funding will enable Metis Foundation to develop advanced medical...
This $2,134,174 Project Grant awarded by the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to the Metis Foundation supports the development of a "sprayable antimicrobial and regeneration promoting foam scaffold for the treatment of non-healing skin wounds." The grant has an award date of September 1, 2023 and a completion date of August 31, 2027. The Metis Foundation, a non-profit organization that supports innovative medical research and education for...
The Defense Health Agency awarded a $264,000 cooperative agreement to the Metis Foundation from September 30, 2022 to September 29, 2025 under the Military Medical Research and Development program (CFDA 12.420). The award will support the Metis Foundation's ACTIVE REJECTION MICRO-PATCH SURVEILLANCE (ARMS) SYSTEM FOR VASCULARIZED COMPOSITE ALLOGRAFTS project located in San Antonio, TX. Through this funding, the Metis Foundation will develop an ARMS system to monitor vascularized composite...
The federal Project Grant award of $1,034,071 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is supporting research by the Metis Foundation on "PROSTATE-SPECIFIC ANTIANDROGEN THERAPY FOR LOCALIZED PROSTATE CANCER." The research aims to develop innovative prostate cancer therapies, building upon Metis Foundation's expertise in conducting medical research, education, and project management support for the military health...
The Defense Health Agency awarded a $1,493,220 Project Grant to The Cleveland VA Medical Research & Education Foundation under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of a "Neurally Integrated Lower Limb Prosthesis for Home and Community Use" to aid mobility and sensory restoration for wounded veterans. The 4-year project, running from September 2023 to August 2027, aligns with the program's priorities of advancing...
The federal Project Grant award, valued at $1,898,000.00, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant is supporting the development of a rapid, fieldable nanopore sequencing-based prognostic and diagnostic assay to advance clinical management decision-making. The primary awardee, The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., will leverage this funding over a 3-year period from...
The Department of the Army Medical Command awarded a $5,599,536 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program to Senseer Health Inc. in Pasadena, CA. The grant supports the development of multimodal diagnostic microsensors for monitoring the status of hydrocephalus shunts over a 4-year period from June 1, 2024 to May 31, 2028. The project aims to advance innovative biomedical technologies that can transform healthcare for military service...
The Defense Health Agency awarded a $2,463,953 Project Grant to Biosensics LLC for the development of a "Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia Spectrum." The award, made under the Military Medical Research and Development program (CFDA 12.420), will fund the creation of innovative wearable sensor technologies and cloud-based software solutions to enable remote monitoring and management of frontotemporal dementia and related...